The Department of Justice has issued a strong warning in recent months to those in the pharmaceutical and healthcare industries: find a way to deter fraud and other corporate corruption, or face hefty consequences.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...